Tullis Health Investors
Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.
Business Model:
Revenue: $10.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Tullis Health Investors Information
Geographic Data
Address: 55 Old Field Point Rd
City: Greenwich
State: CT
Zip: 06830
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.
Contact Phone:
+12036298700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2009 | Vidacare | Series D | 7.6M |
| 12/2011 | Exagen | Venture Round | 12M |
| 5/2011 | Exagen | Venture Round | 5.4M |
| 2/2011 | Exagen | Venture Round | 16.9M |
| 11/2013 | Exagen | Debt Financing | 25M |
| 6/2000 | SupplyPro | Venture Round | 28M |
| 7/2014 | Exagen | Debt Financing | 4M |
| 8/2005 | Adiana | Series D | 23M |
| 10/2014 | CareSync | Series A | 0 |
| 11/1999 | Centromine | Venture Round | 5.1M |
| 3/2004 | TransMolecular | Series C | 0 |
| 3/2010 | Biobdx | Series B | 10M |
| 4/2000 | AmericasDoctor.com | Venture Round | 33.5M |
| 12/2010 | Estech | Series D | 8.5M |
| 4/2008 | Aldagen | Series D | 18.4M |
| 9/2007 | Atritech | Series D | 22M |
| 10/2009 | Synageva BioPharma | Series F | 0 |
| 7/2019 | Exagen | Venture Round | 0 |
| 3/2009 | Atritech | Venture Round | 0 |
| 4/2015 | CareSync | Venture Round | 289k |
| 4/2009 | Synageva BioPharma | Series F | 30M |
| 12/2002 | BioRexis | Series A | 8M |
| 2/2012 | Exagen | Venture Round | 34.1M |
| 2/2007 | Impulse Monitoring, Inc. | Series A | 4.5M |
| 3/2009 | Intranasal Therapeutics | Series B | 0 |
| 1/2004 | Exagen | Series A | 5.4M |
| 9/2012 | Exagen | Series C | 5.3M |
| 9/2000 | TransMolecular | Series B | 0 |
| 10/2009 | Coherex Medical | Series B | 16.5M |
| 11/2004 | Valeo Medical | Series B | 6.2M |
| 12/2015 | TriSalus Life Sciences | Series C | 0 |
| 9/2007 | Aldagen | Series C | 9M |
| 3/2015 | OrthoSensor | Series C | 0 |
| 6/2005 | Exagen | Series B | 7M |
| 3/2004 | BioRexis | Series B | 30M |
| 10/2015 | CareSync | Series B | 0 |
| 12/2003 | Valeo Medical | Series A | 750k |
| 2/2007 | BioBehavioral Diagnostics | Series A | 8.5M |
| 7/2012 | Estech | Venture Round | 122k |
| 1/1997 | TransMolecular | Series A | - |
| 12/2004 | Myocor | Series D | 24M |
| 7/2019 | Exagen | Venture Round | 0 |
| 12/2015 | TriSalus Life Sciences | Series C | 0 |
| 10/2015 | CareSync | Series B | 0 |
| 4/2015 | CareSync | Venture Round | 0 |
| 3/2015 | OrthoSensor | Series C | 0 |
| 10/2014 | CareSync | Series A | 0 |
| 7/2014 | Exagen | Debt Financing | 0 |
| 11/2013 | Exagen | Debt Financing | 0 |
| 9/2012 | Exagen | Series C | 0 |
| 7/2012 | Estech | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
